Legal & General Group’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
MAM
WC
FCM
LG
MCM
AI
IC
Legal & General Group's STIM Position: Q2 2026 in Review
Legal & General Group sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 3,294 shares — an estimated $4.79K sold.
Legal & General Group first reported a position in STIM in Q3 2018 and held it in 16 quarters. The position peaked at $41K in Q2 2021. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.
- Legal & General Group reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
- Legal & General Group sold 3,294 Neuronetics shares in Q2 2026, an estimated $4.79K.
- Legal & General Group first reported a position in Neuronetics in Q3 2018 and held it in 16 quarters.
- Legal & General Group's Neuronetics position peaked at $41K in Q2 2021.
- 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.
Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.